Artivion, Inc.

Ownership Transactions Reported by 24 Insiders

Symbol
AORT on NYSE
Industry
Surgical & Medical Instruments & Apparatus
Location
1655 Roberts Boulevard N W, Kennesaw, GA

Insiders trading volume in the past year

Artivion, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
James P. Mackin President & CEO $21.4M -$3.34M -13.5% Mar 6, 2025
David Ashley Lee Executive VP, COO & CFO $6.66M Mar 1, 2023
John E. Davis Chief Commercial Officer $4.93M -$598K -10.8% Mar 11, 2025
Jean F. Holloway SVP, General Counsel $4.66M -$1.08M -18.8% Mar 11, 2025
Lance A. Berry Executive VP, CFO $3.81M -$211K -5.25% Mar 6, 2025
Amy Horton VP, Chief Accounting Officer $3.64M -$571K -13.6% Mar 6, 2025
Daniel J. Bevevino Director $3.37M May 30, 2024
Thomas F. Ackerman Director $3.36M May 30, 2024
Jon W. Salveson Director $2.89M May 30, 2024
Marshall Stanton SVP, Clinical & MD Affair $2.87M -$168K -5.51% Mar 6, 2025
Ronald D. McCall Director $2.19M Aug 25, 2021
Harvey Morgan Director $1.75M Aug 30, 2021
James Bullock Director $1.46M May 30, 2024
Jeffrey H. Burbank Director $1.11M May 30, 2024
Andrew M. Green VP Regulatory $1.01M -$229K -18.5% Dec 4, 2024
Marna P. Borgstrom Director $1M May 30, 2024
Anthony B. Semedo Director $918K -$189K -17.1% Mar 5, 2025
Rochelle Maney VP, Quality $872K Mar 1, 2024
Matthew A. Getz VP, Human Resources $864K -$238K -21.6% Aug 16, 2024
Dennis Maier SVP, Operations $625K Jun 6, 2023
Elizabeth A. Hoff Director $587K May 30, 2024
Florian Tyrs VP, Global Operations $586K Feb 27, 2024
Franz Peter Barthold VP, Research & Development $585K Nov 8, 2022
Robert Thomson VP Research & Development $251K Feb 23, 2024

Recent Insider Transactions by Companies or Individuals for Artivion, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.